首页> 外国专利> Tumor necrosis factor-related apoptosis-inducing ligand and integrin ligand fusion protein and uses thereof

Tumor necrosis factor-related apoptosis-inducing ligand and integrin ligand fusion protein and uses thereof

机译:肿瘤坏死因子相关的凋亡诱导配体和整联蛋白配体融合蛋白及其用途

摘要

Provided is a fusion protein comprising a tumor necrosis factor related apoptosis inducing ligand (TRAIL), integrin ligands of ±V²3 and ±V²5 and a linking peptide. Also provided are the expression method and simple separation and purification process for the production of the fusion protein which is soluble and has high content of the polymer, and use of the fusion protein for the manufacturing of a medicament for the treatment of tumor. The fusion protein has good tumor tissue targeting property, significantly enhanced anti-tumor effect, which can also reduce the dose of the needed protein for the target treatment effect, improve the bioavailability, reduce the treatment cost, decrease and overcome the potential toxic and side effects of the tumor necrosis factor-related apoptosis inducing ligand.
机译:提供了一种融合蛋白,其包含肿瘤坏死因子相关的凋亡诱导配体(TRAIL),±V 2 3和±V 2 5的整联蛋白配体以及连接肽。还提供了表达方法和简单的分离与纯化方法,用于生产可溶且具有高聚合物含量的融合蛋白,以及该融合蛋白在制备用于治疗肿瘤的药物中的用途。融合蛋白具有良好的肿瘤组织靶向性,显着增强了抗肿瘤作用,还可以减少靶蛋白治疗效果所需蛋白的剂量,提高生物利用度,降低治疗成本,减少并克服潜在的毒副作用。肿瘤坏死因子相关的凋亡诱导配体的作用

著录项

  • 公开/公告号JP2011500066A

    专利类型

  • 公开/公告日2011-01-06

    原文格式PDF

  • 申请/专利权人 南京大学;

    申请/专利号JP20100530249

  • 发明设计人 ▲華▼子春;曹林;

    申请日2008-10-08

  • 分类号C12N15/09;C07K19;C07K14;A61K38;A61K45;A61P35;

  • 国家 JP

  • 入库时间 2022-08-21 18:18:33

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号